COMPASS Pathways plc

$10.69+6.16%(+$0.62)
TickerSpark Score
60/100
Mixed
80
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMPS research report →

52-Week Range90% of range
Low $2.25
Current $10.69
High $11.65

Companycompasspathways.com

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.

CEO
Kabir Kumar Nath
IPO
2020
Employees
166
HQ
London, GB

Price Chart

+131.93% · this period
$10.96$6.66$2.35May 20Nov 18May 20

Valuation

Market Cap
$1.03B
P/E
-6.58
P/S
0.00
P/B
3.60
EV/EBITDA
-1.81
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-151.02%
ROIC
-44.02%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-287,862,000 · -85.57%
EPS
$-3.08 · -33.91%
Op Income
$-179,037,000
FCF YoY
-31.93%

Performance & Tape

52W High
$11.65
52W Low
$2.25
50D MA
$7.49
200D MA
$6.39
Beta
2.40
Avg Volume
3.88M

Get TickerSpark's AI analysis on CMPS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 26, 26Nath Kabirother367,815
Mar 26, 26Nath Kabirother175,000
Mar 26, 26Goodwin Guyother115,600
Mar 26, 26Goodwin Guyother55,000
Mar 26, 26Loxam Teriother157,635
Mar 26, 26Loxam Teriother75,000
Mar 11, 26Nath Kabirother13,131
Mar 11, 26Loxam Teriother1,781
Mar 2, 26Loxam Teriother4,467
Feb 2, 26Nath Kabirother16,181

Our CMPS Coverage

View all →

Want a deeper read on CMPS?

Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.

Generate CMPS Report →

Similar Companies